| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 01/03/2013 | US20130005775 Methods of treating ulcerative colitis |
| 01/03/2013 | US20130005774 Topical foam composition |
| 01/03/2013 | US20130005773 Fluoro-substituted 2-aryl-3,5-dicyano-4-indazolyl-6-methyl-1,4-dihydropyridines and uses thereof |
| 01/03/2013 | US20130005772 Methods for delivering a drug to a hospital patient for short-term use while minimizing long-term use of the drug |
| 01/03/2013 | US20130005771 Oxadiazole compounds, their preparation and use |
| 01/03/2013 | US20130005770 Organic compounds |
| 01/03/2013 | US20130005769 Inhibitors of the interaction between mdm2 and p53 |
| 01/03/2013 | US20130005768 Compositions and methods for the treatment of metabolic disorders |
| 01/03/2013 | US20130005767 Therapeutic compounds |
| 01/03/2013 | US20130005766 5-[(3,3,3-trifluoro-2-hydroxy-1-arylpropyl)amino]-1h-quinolin-2-ones, a process for their production and their use as anti-inflammatory agents |
| 01/03/2013 | US20130005765 Methods and Compositions for Controlling Ectoparasites |
| 01/03/2013 | US20130005764 Quinine dosage forms and methods of use thereof |
| 01/03/2013 | US20130005763 Sustained-release solid preparation for oral use |
| 01/03/2013 | US20130005762 Combination of droloxifene and clopidogrel |
| 01/03/2013 | US20130005761 Process for the manufacture of pharmaceutically active compounds |
| 01/03/2013 | US20130005760 Heterocyclic compound having azole group |
| 01/03/2013 | US20130005759 Small molecule modifiers of microrna mir-122 |
| 01/03/2013 | US20130005758 Manufacture, method and use of drug-eluting medical devices for permanently keeping blood vessels open |
| 01/03/2013 | US20130005757 Pharmaceutical compositions comprising epa and a cardiovascular agent and methods of using the same |
| 01/03/2013 | US20130005756 Method for treating pulmonary diseases using rho kinase inhibitor compounds |
| 01/03/2013 | US20130005755 Peripherally Acting Opioid Compounds |
| 01/03/2013 | US20130005754 Solid forms of (s)-ethyl 2-amino-3-(4-(2-amino-6-((r)-1-(4-chloro-2-(3-methyl-1h-pyrazol-1-yl)phenyl)-2,2,2-trifluoroethoxy)-pyrimidin-4-yl)phenyl)propanoate and methods of their use |
| 01/03/2013 | US20130005753 Heterobicyclic carboxamides as inhibitors for kinases |
| 01/03/2013 | US20130005752 Metalloenzyme inhibitor compounds |
| 01/03/2013 | US20130005751 Heterobicyclic carboxamides as inhibitors for kinases |
| 01/03/2013 | US20130005750 Heterobicyclic carboxamides as inhibitors for kinases |
| 01/03/2013 | US20130005749 Novel formulation and treatment methods |
| 01/03/2013 | US20130005748 Compounds and compositions as protein kinase inhibitors |
| 01/03/2013 | US20130005747 Method for selecting a cancer therapy |
| 01/03/2013 | US20130005746 Inhibitors of brutons tyrosine kinase for the treatment of solid tumors |
| 01/03/2013 | US20130005745 Inhibitors of bruton's tyrosine kinase |
| 01/03/2013 | US20130005744 Inhibitors of catechol o-methyl transferase and their use in the treatment of psychotic disorders |
| 01/03/2013 | US20130005743 New positive allosteric modulators of nicotinic acetylcholine receptor |
| 01/03/2013 | US20130005742 Substituted Diphenylpyrazine Derivatives |
| 01/03/2013 | US20130005741 Substituted pyrimidine as a prostaglandin d2 receptor antagonist |
| 01/03/2013 | US20130005740 Process for preparation of over-the-counter gelatin or pectin-based drug delivery |
| 01/03/2013 | US20130005739 Pharmaceutical preparations comprising a cos releasing compound |
| 01/03/2013 | US20130005738 Monocyclic Heteroaryl Compounds |
| 01/03/2013 | US20130005737 Compositions, methods and kits for treating leukemia |
| 01/03/2013 | US20130005736 Antiviral agents |
| 01/03/2013 | US20130005735 Organic compounds |
| 01/03/2013 | US20130005734 Therapeutic compositions |
| 01/03/2013 | US20130005733 Combination anti-cancer therapy |
| 01/03/2013 | US20130005732 New medical use of triazine derivatives |
| 01/03/2013 | US20130005731 Crystalline forms of neurotrophin mimetic compounds and their salts |
| 01/03/2013 | US20130005730 Novel 1,3-oxazolidine compounds and their use as renin inhibitors |
| 01/03/2013 | US20130005729 Metalloenzyme inhibitor compounds |
| 01/03/2013 | US20130005728 Substituted pyrimidines as prostaglandin d2 receptor antagonists |
| 01/03/2013 | US20130005727 Quinazoline derivatives |
| 01/03/2013 | US20130005726 Compositions and methods for treating inflammatory disorders |
| 01/03/2013 | US20130005725 Chemical compounds |
| 01/03/2013 | US20130005724 Pyridino-pyridinone derivatives, preparation and therapeutic use thereof |
| 01/03/2013 | US20130005723 Triazine compounds as pi3 kinase and mtor inhibitors |
| 01/03/2013 | US20130005722 Pharmaceutical Composition of Mycophenolate Mofetil and Process for Preparing Thereof |
| 01/03/2013 | US20130005721 Indolizine inhibitors of 5-lipoxygenase |
| 01/03/2013 | US20130005720 Pharmaceutical composition for treating cancer and applications thereof |
| 01/03/2013 | US20130005718 Compositions and methods of treating chronic pain by administering propofol derivatives |
| 01/03/2013 | US20130005717 3-aryl-3-hydroxy-2-amino-propionic acid amides, 3-heteroaryl-3-hydroxy-2-amino-propionic acid amides and related compounds having analgesic and/or immuno stimulant activity |
| 01/03/2013 | US20130005716 Derivatives of 1-phenyl-2-pyridinyl alkyl alcohols as phosphodiesterase inhibitors |
| 01/03/2013 | US20130005714 Water-Soluble Meloxicam Granules |
| 01/03/2013 | US20130005713 Process for Preparing Diaminophenothiazinium Compounds |
| 01/03/2013 | US20130005711 Fasudil in combination therapies for the treatment of pulmonary arterial hypertension |
| 01/03/2013 | US20130005710 Aminopyridine derivative |
| 01/03/2013 | US20130005709 Sulfone compounds as 5-ht6 receptor ligands |
| 01/03/2013 | US20130005708 Histamine antagonist treatment of inflammatory skin disorders |
| 01/03/2013 | US20130005707 Aminotriazolopyridines, compositions thereof, and methods of treatment therewith |
| 01/03/2013 | US20130005706 Fused heterocyclic compounds as ion channel modulators |
| 01/03/2013 | US20130005705 Novel inhibitor compounds of phosphodiesterase type 10a |
| 01/03/2013 | US20130005704 Substituted arylimidazolone and triazolone as inhibitors of vasopressin receptors |
| 01/03/2013 | US20130005703 Quinoline compounds suitable for treating disorders that respond to modulation of the serotonin-5-ht6 receptor |
| 01/03/2013 | US20130005702 Pyrazole derivatives as protein kinase modulators |
| 01/03/2013 | US20130005701 Substituted oxazolidinones and their use in the field of blood coagulation |
| 01/03/2013 | US20130005700 Pharmaceutical compositions |
| 01/03/2013 | US20130005699 Methods and products for treatment of diseases |
| 01/03/2013 | US20130005698 Pharmaceutical for preventing or treating an inner ear disorder |
| 01/03/2013 | US20130005697 Progesterone Receptor Antagonists |
| 01/03/2013 | US20130005696 Bufadienolide derivatives, preparing process thereof, composition comprising the same and the use thereof |
| 01/03/2013 | US20130005695 Quiniclidine derivatives of (hetero) arylcycloheptanecarboxylic acid as muscarinic receptor antagonists |
| 01/03/2013 | US20130005694 Liquid compositions comprising vitamin d and uses thereof |
| 01/03/2013 | US20130005693 Method for Reducing Levels of Disease Associated Proteins |
| 01/03/2013 | US20130005692 Synergistic composition and method of retarding and ameliorating photo induced retinal damage and cataracts while ameliorating dry eye syndrome |
| 01/03/2013 | US20130005691 Esters for treatment of ocular inflammatory conditions |
| 01/03/2013 | US20130005690 S-nitrosylation of glucosylating toxins and uses therefor |
| 01/03/2013 | US20130005689 Compounds for the treatment of addiction |
| 01/03/2013 | US20130005687 Imidazolo-, oxazolo-, and thiazolopyrimidine modulators of trpv1 |
| 01/03/2013 | US20130005686 2-Methylene-(22E)-25-Hexanoyl-24-OXO-26,27-Cyclo-22-Dehydro-19-Nor-Vitamin D Analogs |
| 01/03/2013 | US20130005685 Starch derivative mixtures |
| 01/03/2013 | US20130005684 Pharmaceutical composition containing cyclodextrin copolymer |
| 01/03/2013 | US20130005683 Glycine betaine and its use |
| 01/03/2013 | US20130005682 Hydroxytyrosol compositions for treatment of cartilage injuries in joints |
| 01/03/2013 | US20130005681 Compositions and methods for stabilized polysaccharide formulations |
| 01/03/2013 | US20130005680 Pharmaceutical composition comprising vitamin d analogue and cosolvent-surfactant mixture |
| 01/03/2013 | US20130005679 Multivitamin Compositions and Methods for Improving Health |
| 01/03/2013 | US20130005678 Methods and Compositions for Treating or Ameliorating Cancer Using Gemcitabine-5'-Elaidate |
| 01/03/2013 | US20130005677 2'-fluoro-6'-methylene carbocyclic nucleosides and methods of treating viral infections |
| 01/03/2013 | US20130005676 Enhancing the therapeutic effect of acupuncture with adenosine |
| 01/03/2013 | US20130005675 Quinolone compound and pharmaceutical composition |
| 01/03/2013 | US20130005674 Antibacterial 4,5-substituted aminoglycoside analogs having multiple substituents |
| 01/03/2013 | US20130005673 Extracts From Kibdelos Porangium As Antibacterial Agents |
| 01/03/2013 | US20130005670 COMBINATION COMPOSITION, COMPRISING AS ACTIVE INGREDIENTS L-CARNITlNE OR PROPIONYL L-CARNITlNE, FOR THE PREVENTION OR TREATMENT OF CHRONIC VENOUS INSUFFICIENCY |